ImmuSmol

ImmuSmol is specialized in developing antibodies directed against small molecules. Supported by public institutions including BPI, Conseil Régional Nouvelle Aquitaine, as well as by its Co-founder Associate – SCHIEVER, Immusmol is established in Bordeaux, France.
The ImmuSmol team is made up of around twenty talents with different backgrounds and application fields, bringing their expertise and experience to the company. ImmuSmol aims to become a natural choice for small molecule antibodies development, collaborating with a worldwide network of scientists.
ImmuSmol’s focus: validated tools for detecting small molecules
ImmuSmol stands for antibodies against small molecules. While traditional antibodies only recognize large molecules such as proteins, ImmuSmol designs and develops antibodies capable of targeting low molecular weight entities, below 900 Daltons, that can be used for conventional staining applications as well as in the scope of novel immunoassays development
Their products are fully compatible with existing antibody-based technologies, small molecule antibodies are opening a whole new set of possibilities in research diagnostic and therapeutic applications.

The prices are on request! Contact Us by e-mail info@sobekbio.com

DIMA Biotech

DIMA Biotechnology Ltd. is a biotech company focusing on preclinical R&D products and services for druggable targets. They plan to complete the preparation of lead antibody molecules for all druggable targets in the next 3-5 years. DIMA Biotech provides multiple pre-prepared lead antibody molecules for each target to help pharmaceutical companies skip the tedious steps of monoclonal antibody platform establishment and lead molecule screening. Therefore, companies can have more time to focus on the biological mechanism and developability study of drug targets, thus accelerating the process of new drug R&D.

Over the years, DIMA Biotech has been deeply engaged in developing and optimizing the underlying technology platforms for preclinical research. Currently, they have established two independently developed core technology platforms:

Single/multiple transmembrane protein eukaryotic expression, preparation and purification platforms, apply mammalian cell expression systems, provide ECD or full-length membrane protein products closest to native conformation and functional validation. In addition, DIMA Biotech has developed five major functional full-length transmembrane protein preparation systems, including Membrane Nanoparticle (MNP), Virus-Like Particle (VLP), Exosome (EXO), Detergent and Synthetic Nanodisc. Thousands of drug target protein products are in stock.
DimAb® High-throughput single B-cell lead antibody molecule discovery platform. DIMA Biotech has completed the preparation and screening of lead antibody molecules against more than 200 drug targets by this platform in just two years. Moreover, they have formed strategic partnerships with several international pharmaceutical enterprises and licensed several drug target molecules. DIMA’s preclinical development strength is widely recognized by the industry.

www.dimabio.com

The prices are on request! Contact Us by e-mail info@sobekbio.com

Anti-OX40 antibody(DM116), Rabbit mAb DME100116

The add to cart button will appear once you select the values above

Specifications

size	10µg / 100µg / 500µg

Background:

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that this receptor promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4 T cell response, as well as in T cell-dependent B cell proliferation and differentiation.

Synonyms:

TNFRSF4, OX40, CD134, OX40L receptor, ACT35, TXGP1L

Clonality:

Monoclonal

Species reactivity:

Human

Host species:

Rabbit

Taraget:

OX40

Isotype:

Rabbit IgG

Purification:

Purified from cell culture supernatant by affinity chromatography

Applications:

ELISA|Flow Cyt

Recommended dilution:

ELISA 1/5000-10000;Flow Cyt 1/100

Formulation:

Liquid

Precaution:

Research use only

More info:

Email: info@sobekbio.com

Orders:

Email: orders@sobekbio.com